RNA-based therapy can protect from many Covid variants: StudyResearchers at Yale School of Medicine in the US noted that the molecule could lead to new treatments for COVID-19 in immunocompromised pat...
New study suggests that exposure to common cold virus may provide some protection from COVID-19The research found that the common respiratory virus jump-starts the activity of interferon-stimulated genes.
Researchers led by Indian-origin scientist identify genes that fight virus causing COVID-19The study by scientists at Sanford Burnham Prebys Medical Discovery Institute in San Diego, California, was published in the journal Molecu...
Zydus Cadila seeks DCGI nod for use of hepatitis drug for treating coronavirus casesThe interim results indicate that the drug when administered early on, could help patients recover faster and avoid much of the complicatio...
COVID-19: Zydus Cadila gets DGCI nod for phase 3 clinical trials with biological therapyThe company had completed the phase 2 clinical trials with PegiHep last month. In a regulatory filing, Zydus Cadila said it has received ap...
Zydus Cadila completes phase 2 clinical trial in COVID-19 patients with biological therapy PegiHepIn a regulatory filing, Zydus Cadila said "it has successfully completed a phase 2 clinical trial in COVID-19 patients with its biological ...
Covid scientists find a turning point in critical casesThe work highlights the potential for interferon-based therapies to enlarge a slowly accumulating range of Covid-19 treatments.
Some severe Covid-19 cases may be due to faulty genes, misguided antibodies, say scientistsThe research, published in the journal Science, noted that both groups of patients lack type I interferon -- a set of 17 proteins crucial f...
This is why Covid-19 could be life-threatening for some patients“It looks like this virus has one big trick,” said Shane Crotty, a professor in the Center for Infectious Disease and Vaccine Research at t...
Much headway in quest for vaccine: Drugmakers might be one step away from the Covid remedyIn the situation of a grave pandemic engulfing almost all the countries alike, hopes for a cure have brightened with encouraging developmen...
Hepatitis C drug can help improve condition of coronavirus patients: StudyThough there was no change in recovery time, the researchers also found that the interferon therapy if administered after five days of hosp...
Zydus Cadila gets nod from Mexican authority for clinical trials of COVID-19 therapyIn a regulatory filing, Zydus Cadila said it had received approval from the Mexican regulatory authority Cofepris to conduct clinical trial...
Previously known antiviral drug can speed up recovery of COVID-19 patients: StudyAccording to the study, published in the journal Frontiers in Immunology, treatment with the drug interferon(IFN)- α2b may significantly ac...
Zydus Cadila takes a shot at old Hepatitis C injection to treat Covid-19Ahmedabad-based Zydus has initiated talks with the Department of Biotechnology for a compassionate trial. It is also working with the USFDA...
Covid-19: HCG team develops treatment protocol, writes to Drugs Controller GeneralA three-member team at HCG Hospital in Bengaluru has developed a treatment protocol for covid-19 positive patients.
COVID-19: HCG team's find offers hope for treatmentA three-member team at HCG Hospital in Bengaluru has developed a treatment protocol for Covid-19-positive patients. It is centred on inject...
Hepatitis C cure may cost as low as Rs 67,000India is now one of the few countries where generics are available for interferon-free treatment of Hepatitis C.